Outcomes4Me
Sucher für klinische Onkologie-Studien
Brustkrebs
Ort

RECRUITING • Phasen NA • Stufe 0, I, II, III, IV • Post-Menopausal • Interventionell

Folgendes wird aus ClinicalTrials.gov importiert:

3D Ultrasound Breast Imaging

The purpose of this research is to study the efficacy of a new ultrasound imaging method for diagnosis of breast mass.

Breast Cancer

Studiendesign
Studientyp:

INTERVENTIONAL

Geschätzte Einschreibung:

125 Teilnehmer

Aktueller Studienbeginn:

10. November 2021

Zulassungskriterien
Alter für die Studie berechtigt:

18 - 999

Geschlechter für die Studie berechtigt:

female


Arms and Intervention
  • GE Logiq E10 clinical ultrasound scanner

  • Verasonics research scanner

Einschlusskriterien
  • * adult women ≥ 18 years of age.

  • * solid breast lesion and ultrasound guided biopsy (either as part of their clinical care or through participation in other irb-approved studies)

  • * lesion size of 3mm or larger

Ausschlusskriterien
  • * \< 18 years of age.

  • * lacking capacity to consent

  • * pregnant or lactating

  • * receiving cancer therapy such as chemotherapy or radiation therapy

Trial Information at Site
Last Updated:
Studieninformationen
ClinicalTrial.gov ID:

RECRUITING

Estimated Enrollment:

125

Last Updated:

03/28/2025


Trial Contact

Bobbie Ott

Ott.Bobbie@mayo.edu

507-293-0922


Hauptermittler

Shigao Chen, PhD


Studiensponsor

Mayo Clinic

Study Location (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Outcomes4Me

© 2025 Outcomes4Me Inc. All rights reserved.